Joseph E. Wedekind

Find an error

Name: Wedekind, Joseph E.
Organization: University of Rochester , USA
Department:
Title: Associate(PhD)
Co-reporter:Kefang Xie;Mark P. Sowden;Andrew T. Torelli;Geoffrey S. C. Dance;Harold C. Smith
PNAS 2004 Volume 101 (Issue 21 ) pp:8114-8119
Publication Date(Web):2004-05-25
DOI:10.1073/pnas.0400493101
Activation-induced deaminase (AID) uses base deamination for class-switch recombination and somatic hypermutation and is related to the mammalian RNA-editing enzyme apolipoprotein B editing catalytic subunit 1 (APOBEC-1). CDD1 is a yeast ortholog of APOBEC-1 that exhibits cytidine deaminase and RNA-editing activity. Here, we present the crystal structure of CDD1 at 2.0-Å resolution and its use in comparative modeling of APOBEC-1 and AID. The models explain dimerization and the need for trans-acting loops that contribute to active site formation. Substrate selectivity appears to be regulated by a central active site “flap” whose size and flexibility accommodate large substrates in contrast to deaminases of pyrimidine metabolism that bind only small nucleosides or free bases. Most importantly, the results suggested both AID and APOBEC-1 are equally likely to bind single-stranded DNA or RNA, which has implications for the identification of natural AID targets.
Novel protein kinase C
Conventional protein kinase C
triphosphoric acid, mono[2-[(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methoxy]ethyl] ester
9-[5-(fluoromethyl)-3,4-dihydroxyoxolan-2-yl]-3h-purin-6-one
N6-benzoyl-5'-O-DMT-3'-O-TBDMS-adenosine
[2-[(2-amino-6-oxo-3h-purin-9-yl)methoxy]ethoxy-hydroxyphosphoryl] Phosphono Hydrogen Phosphate
Galactose